BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
TGFB1
,
Metabolism of xenobiotics
,
Arthritis
,
Heart
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TSC-115
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for TSC-115
Explore Curated Studies Results
Literature
Most Relevant Literature
Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Port…
Eukaryotic-like gephyrin and cognate membrane receptor coordinate corynebacterial cell division and …
Sex estimation from knee breadth dimensions in a Finnish population.
DivIVA concentrates mycobacterial cell envelope assembly for initiation and stabilization of polar g…
Comparisons of Allergenic and Metazoan Parasite Proteins: Allergy the Price of Immunity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Basimglurant in Children, Adolescents, and Young Adults With TSC
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refrac…
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymp…
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Altera…
Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healt…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ